30 results on '"Sosa-Liprandi, Alvaro"'
Search Results
2. The Attitudes of Physicians Toward Guideline Recommendations for the Management of Dyslipidemia in Clinical Practice - The VIPFARMA ISCP Project
- Author
-
Lopez-Santi, Ricardo, Piskorz, Daniel, Garcia-Zamora, Sebastian, Martinez, Diego, Martinez-Demaria, Diego, Renna, Nicolas, Forte, Ezequiel, Ibarrola, Martin, Igolnikof, Darío, Lorenzatti, Alberto, Alexander, Bryce, Baranchuk, Adrian, Sosa-Liprandi, Alvaro, Martinez, Felipe, and Kaski, Juan Carlos
- Published
- 2023
- Full Text
- View/download PDF
3. Position statement of the Interamerican Society of Cardiology (IASC) on the current guidelines for the prevention, diagnosis and treatment of arterial hypertension 2017–2020
- Author
-
Wyss, Fernando S., Restrepo, Gustavo, Ponte-Negretti, Carlos I., Lanas, Fernando, Pérez, Gonzalo, Sebba Barroso, Weimar, de la Noval, Reynaldo, Paris, Juan Verdejo, Almonte, Claudia, Valdez, Osiris, Gonzales Medina, Ángel, Valoy, Laura Valdez, Puente Barragán, Adriana Cecilia, Cobos, Leonardo, Ullauri, Vladimir, Lara Terán, Joffre, Sosa Liprandi, Álvaro, Piskorz, Daniel, Barbosa, Eduardo, López Jaramillo, Patricio, Parati, Gianfranco, Coca, Antonio, Iñiguez, Andrés, Wyss, Fernando, Lopez-Jaramillo, Patricio, and Ponte-Negretti, Carlos
- Published
- 2020
- Full Text
- View/download PDF
4. Infections and Cardiovascular Disease
- Author
-
Farina, Juan M., primary, Liblik, Kiera, additional, Iomini, Pablo, additional, Miranda-Arboleda, Andrés F., additional, Saldarriaga, Clara, additional, Mendoza, Ivan, additional, Zaidel, Ezequiel J., additional, Rubio-Campal, José M., additional, Sosa-Liprandi, Alvaro, additional, and Baranchuk, Adrian, additional
- Published
- 2023
- Full Text
- View/download PDF
5. Nocturnal Hypertension and Cardiovascular Events at a Buenos Aires City Hospital
- Author
-
Perea, Joaquín, primary, Corzo, Sofía María, additional, García Chamorro, Luis Guillermo, additional, Denner, Germán, additional, Mazuquin, Andrés, additional, Malano, Damián Jesús, additional, Zaidel, Ezequiel José, additional, Sosa Liprandi, Alvaro, additional, and Racki, Mario, additional
- Published
- 2022
- Full Text
- View/download PDF
6. Chapter 14 - Human African Trypanosomiasis & Heart
- Author
-
Farina, Juan María, Alejandro Ortiz, Hector Isaac, Saldarriaga, Clara, Mendoza, Iván, Sosa-Liprandi, Álvaro, and Baranchuk, Adrian
- Published
- 2022
- Full Text
- View/download PDF
7. Chapter 7 - Leishmaniasis & Heart
- Author
-
Farina, Juan María, García-Martínez, Carlos Eduardo, Saldarriaga, Clara, Barbosa de Melo, Marcia, Wyss, Fernando, Sosa-Liprandi, Álvaro, Gupta, Shyla, López-Santi, Ricardo, Mendoza, Iván, Liblik, Kiera, and Baranchuk, Adrian
- Published
- 2022
- Full Text
- View/download PDF
8. Chapter 22 - Cardiovascular Images in Neglected Tropical Diseases
- Author
-
García-Zamora, Sebastián, Álvarez-García, Jesús, Liblik, Kiera, Restrepo, Gustavo, Sosa-Liprandi, Álvaro, and Baranchuk, Adrian
- Published
- 2022
- Full Text
- View/download PDF
9. Cardiac Sarcoidosis: A Clinical Overview
- Author
-
Alba, Ana Carolina, primary, Gupta, Shyla, additional, Kugathasan, Lakshmi, additional, Ha, Andrew, additional, Ochoa, Alejandro, additional, Balter, Meyer, additional, Sosa Liprandi, Alvaro, additional, and Sosa Liprandi, Maria Inés, additional
- Published
- 2021
- Full Text
- View/download PDF
10. Leishmaniasis and Heart
- Author
-
Farina, Juan Mª, primary, García-Martínez, Carlos E., additional, Saldarriaga, Clara, additional, Pérez, Gonzalo E., additional, Barbosa de Melo, Marcia, additional, Wyss, Fernando, additional, Sosa-Liprandi, Alvaro, additional, Ortiz-Lopez, Hector I., additional, Gupta, Shyla, additional, López-Santi, Ricardo, additional, Mendoza, Ivan, additional, and Baranchuk, Adrian, additional
- Published
- 2021
- Full Text
- View/download PDF
11. Clinical practice guideline for transcatheter versus surgical valve replacement in patients with severe aortic stenosis in Latin America
- Author
-
Lamelas, Pablo, primary, Ragusa, Martin Alberto, additional, Bagur, Rodrigo, additional, Jaffer, Iqbal, additional, Ribeiro, Henrique, additional, Baranchuk, Adrian, additional, Wyss, Fernando, additional, Sosa Liprandi, Alvaro, additional, Olivares, Gabriel, additional, Arrais, Magaly, additional, Rendon, Juan Camilo, additional, Catrip, Jorge, additional, Agatiello, Carla, additional, Cura, Fernando, additional, Marchena, Alfaro, additional, Sandoli de Brito Jr, Fabio, additional, Mangione, José A, additional, Damonte, Aníbal, additional, Santaera, Omar, additional, Hidalgo, Pedro, additional, Nieuwlaat, Robby, additional, and Izcovich, Ariel, additional
- Published
- 2021
- Full Text
- View/download PDF
12. Endomyocardiofibrosis: A Systematic Review
- Author
-
Scatularo, Cristhian Emmanuel, primary, Posada Martínez, Edith Liliana, additional, Saldarriaga, Clara, additional, Ballesteros, Oswaldo Andrés, additional, Baranchuk, Adrian, additional, Sosa Liprandi, Alvaro, additional, Wyss, Fernando, additional, and Sosa Liprandi, María Ines, additional
- Published
- 2021
- Full Text
- View/download PDF
13. Chikungunya and the Heart
- Author
-
Cotella, Juan I., primary, Sauce, Ana L., additional, Saldarriaga, Clara I., additional, Perez, Gonzalo E., additional, Farina, Juan M., additional, Wyss, Fernando, additional, Sosa Liprandi, Alvaro, additional, Mendoza, Ivan, additional, Múnera, Ana G., additional, Alexander, Bryce, additional, and Baranchuk, Adrian, additional
- Published
- 2021
- Full Text
- View/download PDF
14. Human African trypanosomiasis & heart
- Author
-
Ortiz, Hector Isaac Alejandro, primary, Farina, Juan Maria, additional, Saldarriaga, Clara, additional, Mendoza, Ivan, additional, Sosa Liprandi, Alvaro, additional, Wyss, Fernando, additional, Burgos, Lucrecia Maria, additional, Alexander, Bryce, additional, and Baranchuk, Adrian, additional
- Published
- 2020
- Full Text
- View/download PDF
15. Personal Safety during the COVID-19 Pandemic: Realities and Perspectives of Healthcare Workers in Latin America
- Author
-
Delgado, Diego, primary, Wyss Quintana, Fernando, additional, Perez, Gonzalo, additional, Sosa Liprandi, Alvaro, additional, Ponte-Negretti, Carlos, additional, Mendoza, Ivan, additional, and Baranchuk, Adrian, additional
- Published
- 2020
- Full Text
- View/download PDF
16. Función de los marcadores humorales en la evaluación pronóstica de la insuficiencia cardíaca
- Author
-
Sosa Liprandi, Álvaro
- Published
- 2005
- Full Text
- View/download PDF
17. Leishmaniasis and Heart.
- Author
-
Farina, Juan Maria, García-Martínez, Carlos E., Saldarriaga, Clara, Pérez, Gonzalo E., Barbosa de Melo, Marcia, Wyss, Fernando, Sosa-Liprandi, Alvaro, Ortiz-Lopez, Hector I., Gupta, Shyla, López-Santi, Ricardo, Mendoza, Ivan, and Baranchuk, Adrian
- Subjects
LEISHMANIASIS ,NEGLECTED diseases ,COMMUNICABLE diseases ,VISCERAL leishmaniasis ,PARASITIC diseases ,POVERTY ,IMMUNOCOMPROMISED patients ,CARDIOTOXICITY ,THERAPEUTICS - Abstract
Copyright of Archivos de Cardiología de México is the property of Publicidad Permanyer SLU and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2022
- Full Text
- View/download PDF
18. Mortalidad hospitalaria y a los 30 días del implante de válvula aórtica percutánea. Utilidad de los diferentes puntajes de riesgo quirúrgico
- Author
-
Cigallini, Ignacio Manuel, Zaidel, Ezequiel, Villarreal, Ricardo, Bettinotti, Marcelo, Sosa Liprandi, Alvaro, Sztejfman, Matias, Cigallini, Ignacio Manuel, Zaidel, Ezequiel, Villarreal, Ricardo, Bettinotti, Marcelo, Sosa Liprandi, Alvaro, and Sztejfman, Matias
- Abstract
Introducción: El implante valvular aórtico percutáneo (IVAP) es una terapéutica reservada para pacientes con estenosis aórtica con elevado riesgo quirúrgico. Los puntajes de riesgo podrían ser útiles para determinar el pronóstico, sin embargo no existen datos acerca de su utilidad en Argentina. Objetivo: Describir las características clínicas de los pacientes sometidos a IVAP en un centro de alta complejidad, y evaluar la mortalidad a corto plazo en función de los diferentes puntajes de riesgo. Material y métodos: Registro unicéntrico prospectivo de pacientes sometidos a IVAP desde el año 2009 hasta 2016. Se describen las características de la población, la técnica implementada y los eventos hospitalarios y a 30 días. Se evaluó la relación entre la mortalidad y los puntajes de riesgo quirúrgico Euroscore logístico, Euroscore II, STS-PROM, y Observant. Resultados: Se incluyeron 88 pacientes consecutivos con un promedio de edad de 80 años (+/-6,68) siendo 43% de sexo masculino. En el 98% de los casos se utilizó la válvula Corevalve® mediante acceso transfemoral. La mortalidad hospitalaria fue del 4% sin registrarse fallecimientos en el seguimiento. Todos los puntajes de riesgo discriminaron significativamente la mortalidad hospitalaria y a 30 días (Euroscore Log 47.5 vs.16, p =0.023; Euroscore II 29.9 vs. 7.28, p<0.001; STS-PROM 17.59 vs. 5.46, p=0.01; Observant Score 13.25 vs. 4.65, p= 0.0048). Conclusiones: En este registro de un centro de alto volumen de pacientes en Argentina, la mortalidad del IVAP fue baja, y todos los puntajes de riesgo evaluados fueron significativamente distintos entre los vivos y los muertos.
- Published
- 2019
19. Contributors
- Author
-
Adrian Baranchuk, Alejandro Ortiz, Hector Isaac, Alexander, Bryce, Álvarez-García, Jesús, Araiza-Garaygordobil, Diego, Balamane, Saad, Ballesteros, Oswaldo Andrés, Barbosa de Melo, Marcia, Burgos, Lucrecia Maria, Byun, Jin, Carta, Karina Gonzalez, Cotella, Juan Ignacio, Echeverría, Luis Eduardo, Farina, Juan María, García-Martínez, Carlos Eduardo, García-Zamora, Sebastián, Gazendam, Naomi, Gonzalez-Barrera, Luis Gerardo, Gupta, Shyla, Gutierrez, Alejandra González, Krishnan, Dhruv, Lanas, Fernando, Liblik, Kiera, López-López, José Patricio, López-Santi, Ricardo, Martínez-Sellés, Manuel, Mendoza, Iván, Miranda-Arboleda, Andrés Felipe, Noval, María Gabriela, Pérez, Gonzalo Emanuel, Ponte-Negretti, Carlos I., Posada-Martínez, Edith Liliana, Restrepo, Gustavo, Saldarriaga, Clara, Sanders, Prashanthan, Sauce Pérez, Ana Laura, Scatularo, Cristhian Emmanuel, Scott, Laura, Sharma, Arjun, Sosa-Liprandi, Álvaro, Sueldo, Mildren del, Tso, Melissa, Wyss, Fernando, Yeung, Cynthia, Zaidel, Ezequiel José, and Zhou, Zier
- Published
- 2022
- Full Text
- View/download PDF
20. Ambulatory Patients with Cardiometabolic Disease and Without Evidence of COVID-19 During the Pandemic. The CorCOVID LATAM Study.
- Author
-
Santi, Ricardo Lopez, Márquez, Manlio F., Piskorz, Daniel, Saldarriaga, Clara, Lorenzatti, Alberto, Wyss, Fernando, Valdés Martín, Alexander, Sotomayor Perales, Jorge, Carrion Arcela, Jean, Rojas Gimon, Elirub de Lourdes, Sambadaro, Gustavo, Emanuel Perez, Gonzalo, Mendoza, Ivan, Lanas, Fernando, Flores, Roberto, Sosa Liprandi, Alvaro, Alexander, Bryce, and Baranchuk, Adrian
- Abstract
Background: SARS-CoV-2 pandemic has modified the cardiovascular care of ambulatory patients. The aim of this survey was to study changes in lifestyle habits, treatment adherence, and mental health status in patients with cardiometabolic disease, but no clinical evidence of COVID-19. Methods: A cross-sectional survey was conducted in ambulatory patients with cardiometabolic disease using paper/digital surveys. Variables investigated included socioeconomic status, physical activity, diet, tobacco use, alcohol intake, treatment discontinuation, and psychological symptoms. Results: A total of 4,216 patients (50.9% males, mean age 60.3 ± 15.3 years old) from 13 Spanish-speaking Latin American countries were enrolled. Among the study population, 46.4% of patients did not have contact with a healthcare provider, 31.5% reported access barriers to treatments and 17% discontinued some medication. Multivariate analysis showed that nonadherence to treatment was more prevalent in the secondary prevention group: peripheral vascular disease (OR 1.55, CI 1.08-2.24; p = 0.018), heart failure (OR 1.36, CI 1.05-1.75; p = 0.017), and coronary artery disease (OR 1.29 CI 1.04-1.60; p = 0.018). No physical activity was reported by 38% of patients. Only 15% of patients met minimum recommendations of physical activity (more than 150 minutes/week) and vegetable and fruit intake. Low/very low income (45.5%) was associated with a lower level of physical activity (p < 0.0001), less fruit and vegetables intake (p < 0.0001), more tobacco use (p < 0.001) and perception of depression (p < 0.001). Low educational level was also associated with the perception of depression (OR 1.46, CI 1.26-1.70; p < 0.01). Conclusions: Patients with cardiometabolic disease but without clinical evidence of COVID-19 showed significant medication non-adherence, especially in secondary prevention patients. Deterioration in lifestyle habits and appearance of depressive symptoms during the pandemic were frequent and related to socioeconomic status. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
21. Neglected Tropical Diseases and Other Infectious Diseases Affecting the Heart. The NET-Heart Project: Rationale and Design.
- Author
-
Burgos, Lucrecia M., Farina, Juan, Cousirat Liendro, Macarena, Saldarriaga, Clara, Sosa Liprandi, Alvaro, Wyss, Fernando, Mendoza, Ivan, and Baranchuk, Adrian
- Abstract
Introduction: Neglected tropical diseases (NTDs) are a group of infections that are prevalent in many of the tropical and sub-tropical developing countries where poverty is rampant. NTDs have remained largely unnoticed in the global health agenda. There is a substantial gap between the burden of disease for NTDs in cardiovascular diseases (CVD) and research devoted to the affected populations. We created a Latin-American initiative with emerging leaders (EL) from the Interamerican Society of Cardiology (IASC) with the objective to perform multiple systematic reviews of NTDs and other infectious diseases affecting the heart: The NET-Heart Project. Objective: To describe the rationale and design considerations of the NET-Heart project. Methods: The NET-Heart Project is a collaborative work of the IASC EL program. The main objective of the NET-Heart project is to systematically evaluate the available evidence of NTDs and other infectious diseases and their cardiovascular involvement. As a secondary objective, this initiative aims to offer recommendations and potential diagnostic and therapeutic algorithms that can aid the management of cardiovascular complications of these infectious diseases. After an expert discussion 17 initial infectious diseases were selected, for each disease we created one working group. The project was structured in different phases: Systematic review, brainstorming workshops, analysis and results, manuscript writing and recommendations and evaluation of clinical implications. Conclusion: The NET-Heart project is an innovative collaborative initiative created to assess burden and impact of NTDs and other infectious diseases in CVD. NTDs can no longer be ignored and must be prioritised on the health and research agenda. This project aims to review in depth the evidence regarding cardiac compromise of these serious conditions and to propose strategies to overcome barriers for efficient diagnosis and treatment of cardiovascular complications. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
22. Influenza and Pneumococcal Vaccination in Patients with Cardiovascular Disease: Pilot Project
- Author
-
Villarreal, Ricardo, Zaidel, Ezequiel, Cestari, Germán, Mele, Eduardo F., Sosa Liprandi, María Inés, Sosa Liprandi, Alvaro, Villarreal, Ricardo, Zaidel, Ezequiel, Cestari, Germán, Mele, Eduardo F., Sosa Liprandi, María Inés, and Sosa Liprandi, Alvaro
- Abstract
Introducción Se recomienda la vacunación antiinfluenza y antineumocóccica en adultos con trastornos cardiovasculares, pero existe una subutilización de las mismas. Objetivo Describir la tasa de inmunización de los pacientes luego de la indicación sistemática de las vacunas antigripal y antineumocóccica, y las barreras en su implementación. Evaluar si la indicación desde la unidad coronaria se asocia con mayor adherencia. Métodos Estudio unicéntrico prospectivo. Durante un mes en época epidémica, se prescribió sistemáticamente vacunación antigripal y antineumocóccica al egreso de unidad coronaria ó en consultorios externos a pacientes con indicación para las mismas. Seguimiento a 30 días con contacto telefónico. Resultados Se reclutaron 80 pacientes, mediana 65 años, 67% masculinos, 8% cobertura de salud prepaga y el resto obras sociales. 31% indicación de inmunización al egreso de unidad coronaria. Durante el seguimiento sólo 72% se habían inmunizado con la vacuna antigripal y 45% con la antineumocóccica. Los principales motivos descriptos para no inmunización fueron decisión personal del paciente, problemas de obra social y costos de las vacunas. Se observó tendencia a mayor inmunización antineumocóccica si la indicación se realizaba desde la unidad coronaria en comparación con los consultorios (OR 1,47[0,5-4] p=0,2). Conclusiones Un gran porcentaje de los pacientes a los que se les indican las vacunas no se inmunizan efectivamente, siendo la principal barrera la decisión personal. La tendencia a mayor tasa de inmunización al egreso de unidad coronaria en comparación con el consultorio es una potencial oportunidad para mejorar la adherencia, que debería ser demostrada en estudios de mayor escala.
- Published
- 2016
23. Statins at Discharge in Acute Coronary Syndromes over the past 10 Years. The Epi-Cardio Registry
- Author
-
Tajer, Carlos Daniel, Travetto, Carolina, Bacigalupe, Juan José, Martínez, María José, Abreu, Maximiliano de, Mariani, Javier, Sosa Liprandi, Alvaro, Charask, Adrián, Gagliardi, Juan A., Doval, Hernán C., Tajer, Carlos Daniel, Travetto, Carolina, Bacigalupe, Juan José, Martínez, María José, Abreu, Maximiliano de, Mariani, Javier, Sosa Liprandi, Alvaro, Charask, Adrián, Gagliardi, Juan A., and Doval, Hernán C.
- Abstract
Background: Statins have been incorporated for secondary prevention of cardiovascular disease for over two decades, with a remarkable impact in reducing morbidity and mortality. Currently, the evidence available recommends the use of high-intensity statin therapy in all the patients presenting an acute coronary syndrome. Objective: The aim of this study was to evaluate the use of statins at discharge in acute coronary syndrome patients included in the Epi-Cardio registry and its variation over the past 10 years. Methods: Patients hospitalized between 2005 and 2014 with diagnosis of acute coronary syndrome were included; those deceased or without data of the treatment at discharge were excluded. The frequency of indication of statins, agents, doses used over the 10-year period and the indication of high-intensity therapy (rosuvastatin 20-40 mg, atorvastatin 40-80 mg) were analyzed. The use according to the field of care was compared. Results: 22,905 records were analyzed. The most common agents used were atorvastatin 68%, simvastatin 22.7% and rosuvastatin 9.1%. The temporal trend revealed higher frequency of statin prescription (from 83% in 2005-2007 to 92.5% in 2014), higher doses, lower indication of simvastatin and higher of other agents, and greater use of high-intensity statin therapy from 7.7% in 2005-2007 to 52.6% in 2014. The use of high-intensity therapy was lower in the public health care system.Conclusions: The frequency of statin indication reaches optimal levels and the use of high-intensity therapy increased during the period evaluated, including over half of the patients. The differences in the public health care system suggest a lower access to treatment. Additional studies are necessary to identify the barriers for implementing high-intensity statin therapy., OBJETIVO: Evaluar el empleo de estatinas al alta en pacientes con síndrome coronario agudo incluidos en el registro Epi-Cardio y su variación en los últimos 10 años. MATERIAL Y METODO: Se incluyeron los pacientes con síndrome coronario agudo ingresados entre 2005 y 2014, excluyendo fallecidos o sin datos del tratamiento al alta. Se analizó la frecuencia de indicación de estatinas, fármacos y dosis utilizadas a lo largo de los 10 años, así como la indicación de terapia de alta intensidad (rosuvastatina 20-40mg, atorvastatina 40-80mg). Se comparó el uso de acuerdo al ámbito de atención de la salud. RESULTADOS: Se analizaron 22905 registros. Los fármacos más empleados fueron atorvastatina 68%, simvastatina 22,7% y rosuvastatina 9,1%. Las tendencias temporales fueron significativas hacia el incremento de la indicación de estatinas (83% en 2005-2007 a 92,5% en 2014), aumento de las dosis, reducción de la indicación de simvastatina en favor de los otros agentes, e incremento de la terapia de alta intensidad de 7,7% en 2005-2007 al 52,6% en 2014. El empleo de terapia de alta intensidad fue menor en el ámbito público. CONCLUSION: La frecuencia de indicación de estatinas se acerca a niveles óptimos, y el empleo de dosis elevadas se incrementó durante el período de estudio alcanzando a más de la mitad de los pacientes. Las diferencias en el sector público sugieren un menor acceso al tratamiento. Son necesarios estudios adicionales que identifiquen las barreras para implementar los regímenes de elevada intensidad.
- Published
- 2016
24. Impact of a Meditation Program on Pulse-Wave Velocity, C-Reactive Protein and Quality of Life
- Author
-
Huerín, Melina, Masson, Walter, Lobo, Martín, Rodríguez, Julieta, Lago, Noemí, Rostan, María, Sosa Liprandi, Alvaro, Huerín, Melina, Masson, Walter, Lobo, Martín, Rodríguez, Julieta, Lago, Noemí, Rostan, María, and Sosa Liprandi, Alvaro
- Abstract
Background: Although various studies refer to the effect of meditation on blood pressure (BP), its impact on other cardiovascularclinical variables is unknown.Objective: The aim of this study was to evaluate the effects of a meditation program on pulse wave velocity (PWV), quality oflife and ultrasensitive C-reactive protein (us-CRP) in patients with ischemic heart disease or chronic heart failure.Methods: This was a randomized study with two groups of patients: a meditation group (M) and an active control group (AC)with cardiovascular health education, evaluating the difference between initial and final values at 12 weeks of BP, PWV, qualityof life (assessed by the SF-36 questionnaire) and us-CRP.Results: Thirty-five patients were included in the M group and 35 in the AC group; mean age was 61 years and 80% weremen. Both groups had similar baseline characteristics, except for higher number of smokers and triglyceride levels in the Mgroup. At 12 weeks, no significant differences were found for DPWV: +0.51 (±1.40) in AC and +0.19 (±1.53) in M (p=0.37).Conversely, DSF-36 was +0.79 (±7.58) in AC vs. +5.40 (±9.69) (p=0.03) in M, and Dus-CRP was +1.17 (±2.9) in AC vs. -0.69(±0.89) in M (p=0.02).Conclusions: A meditation program did not significantly modify PWV at 12 weeks. However, patients allocated to this interventionimproved their quality of life and us-CRP was significantly reduced. Larger studies are required to confirm thesefindings and explore the mechanisms involved in this improvement., Introducción: Si bien existen publicaciones referentes al efecto de la meditación en la presión arterial (PA), su impacto en otrasvariables clínicas cardiovasculares se desconoce.Objetivos: Evaluar el impacto de un programa de meditación en la velocidad de la onda de pulso (VOP), la calidad de vida y laproteína C reactiva ultrasensible (PCRus) en pacientes con cardiopatía isquémica o insuficiencia cardíaca estable.Material y métodos: Estudio aleatorizado, conformado por dos grupos de pacientes: meditación (M) y control activo (CA) deeducación cardiovascular. Se evaluaron diferencias entre valores iniciales y finales a las 12 semanas de la PA, la VOP, la calidadde vida (valorada por el cuestionario SF-36) y la PCRus.Resultados: Se incluyeron 35 pacientes en el grupo M y 35 en el CA; edad media de 61 años, 80% hombres. Las característicasbasales de ambos grupos fueron similares a excepción del mayor número de tabaquistas y triglicéridos más elevados en elgrupo M. Al cabo de 12 semanas, el delta VOP no tuvo diferencias significativas: +0,51 (± 1,40) en CA y +0,19 (± 1,53) en M(p = 0,37). El delta SF-36 fue de +0,79 (± 7,58) vs. +5,40 (± 9,69) (p = 0,03) en CA y M, respectivamente, y el delta PCRusfue de +1,17 (± 2,9) en CA vs. -0,69 (± 0,89) en M (p = 0,02).Conclusiones: Un programa de meditación no modificó significativamente la VOP a las 12 semanas. Sin embargo, en lospacientes asignados a esta intervención su calidad de vida mejoró y la PCRus se redujo en forma significativa. Se requierenestudios de mayor tamaño que confirmen estos hallazgos y exploren los mecanismos involucrados en esta mejoría.
- Published
- 2015
25. Arritmia ventricular en el postoperatorio inmediato de cirugía cardiovascular
- Author
-
M. Iglesias, Ricardo, M. Baranchuk, Adrián, D.Darú, Víctor, A.González, Miguel, A.Piazza, Ramón, A.Muratore, Claudio, and Sosa Liprandi, Alvaro
- Subjects
Coronary disease ,Enfermedad coronaria ,Taquiarritmias ,Revascularization ,cardiovascular system ,Revascualrización ,cardiovascular diseases ,Tachyarrhythmias - Abstract
Objetivos: Determinar la incidencia, factores predisponentes y la evolución hospitalaria de la arritmia ventricular compleja en el postoperatorio inmediato de cirugía cardíaca. Material y métodos: Se analizó las primeras 96 hs. del postoperatorio de cirugía cardíaca en 355 pacientes (pts) consecutivos, considerando como arritmia ventricular compleja (AC) a la taquicardia ventricular autolimitada, sostenida y fibrilación ventricular. Se registraron factores predisponentes pre, intra y postoperatorios y la evolución hospitalaria. Resultados: Se efectuó revascularización miocárdica en 273 pts (77%), cirugía valvular en 74 pts (21%)y procedimientos combinados en 8 pts (2%). Presentaron AC 25 pts (7%), detectando Taquicardia Ventricular Autolimitada en 7 pacientes (28%), Taquicardia Ventricular Sostenida en 11 pts (44%) y Fibrilación Ventricular en 7 pts (28%). La Arritmia ventricular compleja resultó más frecuente en pts sometidos a revascularización miocárdica (9,1%vs.0%;p
- Published
- 2004
26. Problemas y soluciones en la implementación de un Programa de Implante Valvular Aórtico Percutáneo
- Author
-
Sztejfman, Matias, Sztejfman, Carlos, Albertal, Mariano, Gómez Márquez, Ramón, Goldsmit, Alejandro, Chiminella, Fernando G., Percio, Hernán del, Malusardi, Adriano, Sosa Liprandi, Alvaro, Bettinotti, Marcelo, Sztejfman, Matias, Sztejfman, Carlos, Albertal, Mariano, Gómez Márquez, Ramón, Goldsmit, Alejandro, Chiminella, Fernando G., Percio, Hernán del, Malusardi, Adriano, Sosa Liprandi, Alvaro, and Bettinotti, Marcelo
- Abstract
Introducción La sobrevida de la estenosis aórtica grave sintomática inoperable es baja. El implante percutáneo de válvula aórtica (IVAP) representa una alternativa para estos pacientes. Es nuestra práctica que los candidatos a IVAP ingresen en un programa de evaluación (Programa de IVAP) para determinar su elegibilidad clínica para, luego, solicitar la aprobación a la cobertura de salud. Objetivos Evaluar las causas de la exclusión de pacientes del procedimiento y su impacto clínico. Material y métodos Desde abril de 2009 hasta agosto de 2011, 37 pacientes ingresaron en el Programa de IVAP. Resultados De los 37 pacientes, 29 recibieron el tratamiento o fueron descartados: 14 fueron sometidos a IVAP (grupo IVAP, 48,3%) y 15 fueron descartados (grupo no IVAP 52,7%). Del grupo no IVAP, seis pacientes (40%) fueron descartados por el Programa y cuatro por la cobertura médica, mientras que otros cinco pacientes fallecieron aguardando la autorización. La mediana de EuroSCORE de la población fue del 22% (rango 10-56%) y el promedio de edad fue de 79 ± 8 años. En un seguimiento de 12 meses, la mortalidad del grupo IVAP y no IVAP fue del 7,1% y del 33,3%, respectivamente (p = 0,082). La mortalidad cardiovascular total fue del 17,2%, en todos los casos del grupo no IVAP. Conclusión En nuestro medio, más de la mitad de los pacientes evaluados en un Programa de IVAP no son intervenidos. Razones médicas y socioeconómicas inciden en la toma de decisiones y en la realización o no del IVAP, observándose una mortalidad importante en los pacientes no tratados.
- Published
- 2013
27. Crisis económico-financieras en la Argentina: ¿un nuevo factor de riesgo de mortalidad cardiovascular?
- Author
-
Sosa Liprandi, María Inés, Racki, Mario, Khoury, Marina, Villarreal, Ricardo, Cestari, Germán, Mele, Eduardo F., Sosa Liprandi, Alvaro, Sosa Liprandi, María Inés, Racki, Mario, Khoury, Marina, Villarreal, Ricardo, Cestari, Germán, Mele, Eduardo F., and Sosa Liprandi, Alvaro
- Abstract
Introduccion En estudios clinicos y experimentales se ha documentado la relacion entre el impacto generado por diversas situaciones traumaticas, como guerras, ataques terroristas y desastres naturales, y la mortalidad en diferentes regiones del mundo y los resultados de un estudio reciente muestran que las crisis financieras, en ausencia de desastres naturales o guerras, podrian tener un impacto negativo sobre la mortalidad cardiovascular. La experiencia actual sugiere que las crisis del sistema financiero podrian tener una influencia importante sobre la salud. Objetivos Describir las tendencias de las tasas de mortalidad cardiovascular (TMCV) en la Argentina entre los anos 1995 y 2005 y explorar si los cambios en ellas coinciden temporalmente con cambios en las tendencias del Producto Interno Bruto (PIB) como indicador de crisis economico-financieras. Material y metodos Se calculo la TMCV anual por 100.000 utilizando la base de datos del Ministerio de Salud de la Nacion (Clasificacion Internacional de Enfermedades 9.o y 10.o). Se consideraron las siguientes causas de defuncion: insuficiencia cardiaca (IC), infarto agudo de miocardio (IAM), enfermedad coronaria (EC) cronica y accidente cerebrovascular (ACV). Para los denominadores se utilizaron las proyecciones de poblacion del Instituto Nacional de Estadistica y Censos. Se identificaron dos crisis economicas: la del sudeste asiatico (1998-1999) y la caida de la convertibilidad (2001- 2002). Se aplicaron modelos de joinpoint para evaluar los cambios en las tendencias. Resultados El PIB presento una tendencia ascendente (pendiente = 17,18) desde 1995 hasta 1998, luego una tendencia descendente (pendiente = .12,90) hasta 2002 y una tendencia ascendente (pendiente = 19,88) hasta 2005 y la TMCV descendio un 24,72% (de 474,9 a 357,5 por 100.000). El modelo de joinpoint identifico tres pendientes en la TMCV: la primera desde 1995 hasta 1997 de .17,94, la segunda hasta 2002 con una tendencia al descenso (pendiente = .6,8), Background The relationship between the impact generated by diverse traumatic situations as wars, terrorist attacks and natural disasters with mortality in different regions of the world has been documented in clinical and experimental studies. A recent study showed that, in the absence of natural disasters or wars, financial crises might have a negative impact on cardiovascular mortality. The current experience suggests that financial crises could have a significant influence on health. Objective To describe the trends in cardiovascular mortality rates (CVMR) in Argentina between 1995 and 2005, and to explore if there is a close temporal relationship with the changes in trends of the Gross Domestic Product (GDP) as indicator of economic and financial crisis. Material and Methods The annual CVMR per 100,000 persons was calculated using the information obtained from the database of the Ministry of Health (9th and 10th International Classification of Diseases). The following causes of death were considered: heart failure (HF), acute myocardial infarction (AMI), chronic ischemic heart disease (IHD) and stroke (CVA). The population estimates used as the denominator were obtained from the National Institute of Statistics and Censuses. Two economic crises were identified: the Southeast Asia crisis (1998-1999) and the end of the convertibility system (2001-2002). Joinpoint models were used to evaluate changes in trends. Results GDP showed an increasing trend (slope = 17.18) from 1995 to 1998, which decreased in the period 1998-2002 (slope = 12.90) and increased from 2002 to 2005 (slope = 19.88); CVMR decreased by 24.72% (from 474.9 to 357.5 per 100,000). The joinpoint model identified three slopes in CVMR: from 1995 to 1997 ( 17.94), a descending slope until 2002 ( 6.8) and an increasing slope until 2005 (slope 16.73). Mortality rates due to HF, MI and CVA had a similar trend, decreasing by 22.95%, 16.89% and 38.06%, respectively. Conclusions The close temporal relationshi
- Published
- 2012
28. [Neglected tropical diseases and their impact on cardiovascular health (The NET-Heart Project)].
- Author
-
Iomini PA, Parodi JB, Farina JM, Saldarriaga C, Liblik K, Mendoza I, Sosa Liprandi A, Wyss F, Martínez-Sellés M, Burgos LM, and Baranchuk A
- Subjects
- Humans, Neglected Diseases epidemiology, Cardiovascular System, Tropical Medicine
- Abstract
Neglected tropical diseases (NTD) are a group of diseases with high prevalence in tropical and subtropical countries. They are associated to poverty and underdevelopment. Due to its high morbimortality, these conditions are considered a health crisis. The impact of these diseases can be worsened by the poor socioeconomic status of the affected countries, most of them under-developed, which affects the health care provided to patients. The morbidity of these diseases is explained by the wide organic impairment that they produce. The cardiovascular system is particularly affected, which explains the high morbimortality of NTD. In this article, we review the key issues of a project elaborated by Emerging Leaders of the Interamerican Society of Cardiology (SIAC), about the cardiovascular impact of NTD: the NET-Heart Project (Neglected Tropical Diseases and other Infectious Diseases affecting the Heart).
- Published
- 2021
29. [Influenza and pneumococcal immunization in cardiovascular prevention].
- Author
-
Sosa Liprandi MI, Sosa Liprandi A, Fernández A, Stecher D, Bonvehí P, and Verón MT
- Subjects
- Argentina, Cardiovascular Diseases prevention & control, Cost-Benefit Analysis, Government Agencies, Humans, Immunization economics, Review Literature as Topic, Acute Coronary Syndrome prevention & control, Influenza, Human prevention & control, Myocardial Infarction prevention & control, Pneumococcal Infections prevention & control, Pneumococcal Vaccines administration & dosage, Vaccination economics
- Abstract
A group of interdisciplinary experts (cardiologists, clinicians, infectologists met with the purpose of analyzing the evidence revealed by the relationship between respiratory diseases caused by influenza, pneumococcal diseases and cardiovascular events, and the role played by immunization strategies applied in cardiovascular prevention. The present statement summarizes the conclusions reached by the expertise of the aforementioned professionals. Systematic revisions imply consistent evidence that influenza and pneumococcal infection lead to acute myocardial infarction and cardiovascular death. Studies published during the last 15 years suggest that vaccination against influenza and S. pneumoniae reduce the risk of acute coronary syndromes. With the current evidence, and considering cost-effectiveness, reducing operating expenses and safety profile of the vaccines, scientific societies, national and international government health agencies strongly recommend incorporating immunization programs in those patients with chronic cardiovascular disease.
- Published
- 2014
30. Overview of acute decompensated heart failure in Argentina: lessons learned from 5 registries during the last decade.
- Author
-
Perna ER, Barbagelata A, Grinfeld L, García Ben M, Címbaro Canella JP, Bayol PA, and Sosa Liprandi A
- Subjects
- Aged, Argentina, Female, Hospitalization, Humans, Male, Heart Failure diagnosis, Heart Failure drug therapy, Registries
- Abstract
Background: The acute decompensated heart failure (ADHF) is not as well characterized as the chronic phase, particularly in Latin American countries. Thus, the aim of this overview was to describe the clinical profile, treatment, and inhospital course of ADHF during the last decade in Argentina., Methods: Results obtained from 5 Argentinean prospective and multicenter registries, involving 2974 patients admitted for ADHF, were assessed. These registries were performed and published between 1992 and 2004., Results: The mean age was 65 to 70 years, and nearly 40% were female. Coronary artery disease was the main etiology in nearly 30% of the patients. Between 1992 and 2004, the use of angiotensin-converting enzyme inhibitors increased from 29.9% to 53.4% before admission and from 48.5% to 69.3% before discharge; the use of beta-blockers rose from 4.2% to 33.2% at admission and from 2.5% to 42.4% at predischarge (all P < .0001). Inhospital mortality rates in the first to the fifth registries were 12.1%, 4.6%, 10.5%, 8.9%, and 4.7% (P [trend] = .006). However, there were 98 (7.7%) deaths among 1272 patients before 2002, compared with 129 (7.6%) among 1702 since 2002 (P = .9)., Conclusions: The clinical profile of this largest sample of ADHF reported from a Latin American country is different from that observed in clinical trials and comparable to registries worldwide. Although an improvement in the use of recommended drugs was observed in the last decade, the average mortality has not changed. These findings might have implications in the design of multinational clinical trials.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.